Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
---|---|---|---|---|
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US10556010 | PHOTOCURE ASA | Neoadjuvant therapy for bladder cancer |
Dec, 2036
(13 years from now) | |
US11311620 | PHOTOCURE ASA | Neoadjuvant therapy for bladder cancer |
Dec, 2036
(13 years from now) | |
US11235168 | PHOTOCURE ASA | Method of photodynamic therapy (PDT) for bladder cancer |
Jan, 2038
(14 years from now) |
Drugs and Companies using HEXAMINOLEVULINATE HYDROCHLORIDE ingredient
Market Authorisation Date: 28 May, 2010
Treatment: Detection of carcinoma in the bladder by photodynamic cystoscopy
Dosage: FOR SOLUTION;INTRAVESICAL
5
United States
5
European Union
2
Korea, Republic of
2
Australia
2
Russia
2
Canada
2
Japan
2
China
2
Brazil
1
United Kingdom
1
Israel
1
Poland
1
Chile
1
Singapore
1
Denmark
1
South Africa
1
Spain
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic